Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 16966687

Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2006 Oct 10
First author
Pfisterer J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Curr Oncol Rep. 2007 Nov;9(6):469-71. doi: 10.1007/s11912-007-0065-5.
    note
    Source null
    related pmid
    17991354
    relationship
    Comment in

Authors and identifiers

  1. name
    Pfisterer J
    type
    Author
  2. name
    Plante M
    type
    Author
  3. name
    Vergote I
    type
    Author
  4. name
    du Bois A
    type
    Author
  5. name
    Hirte H
    type
    Author
  6. name
    Lacave AJ
    type
    Author
  7. name
    Wagner U
    type
    Author
  8. name
    Stähle A
    type
    Author
  9. name
    Stuart G
    type
    Author
  10. name
    Kimmig R
    type
    Author
  11. name
    Olbricht S
    type
    Author
  12. name
    Le T
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Pfisterer J
    type
    Author
  2. name
    Plante M
    type
    Author
  3. name
    Vergote I
    type
    Author
  4. name
    du Bois A
    type
    Author
  5. name
    Hirte H
    type
    Author
  6. name
    Lacave AJ
    type
    Author
  7. name
    Wagner U
    type
    Author
  8. name
    Stähle A
    type
    Author
  9. name
    Stuart G
    type
    Author
  10. name
    Kimmig R
    type
    Author
  11. name
    Olbricht S
    type
    Author
  12. name
    Le T
    type
    Author
bibliography ids
  1. nci-bib-c74d7fc3a12ac309b725fa50
book metadata
content sha256
9ae7021b73e4d2468a735dd0daf2e139771f3ebd1bacf5323174eaf83e022bba
document type
citation
dois
  1. 10.1200/JCO.2006.06.0913
electronic publication date
display
2006 Sep 11
precision
day
year
2006
evidence scope
bibliographic_metadata_only
id
pubmed:16966687
immutable id
pubmed:16966687@9ae7021b73e4d2468a735dd0daf2e139771f3ebd1bacf5323174eaf83e022bba
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
29
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
4699-707
volume
24
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Curr Oncol Rep. 2007 Nov;9(6):469-71. doi: 10.1007/s11912-007-0065-5.
    note
    Source null
    related pmid
    17991354
    relationship
    Comment in
outcomes validated
false
pmid
16966687
provenance
batch id
2c499a3b9f4867a74c49
provider
NCBI PubMed ESummary
record sha256
a2e49f2d575de79ea3fecde132d7381e1d6ea738f77aa782d6141519de751738
response sha256
3b299651c5c5270455877b65b6e5acff71ad5f85103b7f9582efe63c52588326
retrieved at
2026-09-09T23:46:08.887541+00:00
publication date
display
2006 Oct 10
precision
day
year
2006
publication types
  1. Journal Article
  2. Multicenter Study
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/16966687/
title
Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG.

Preserved source evidence · Not medical advice